Ebglyss (lebrikizumab) - Roche, Almirall, Eli Lilly
Cibinqo (abrocitinib) - Pfizer
Opzelura (ruxolitinib cream) - Incyte, Maruho
Vtama (tapinarof) - Roivant, Japan Tobacco
Jakafi (ruxolitinib) - Novartis, Incyte
Adbry (tralokinumab-ldrm) - LEO Pharma, AstraZeneca
Moizerto (difamilast) - Otsuka, Medimetriks
Daliresp (roflumilast) - AstraZeneca, Takeda, AbbVie
Rinvoq (upadacitinib) - AbbVie
Corectim (delgocitinib) - Japan Tobacco, LEO Pharma, Rohto Pharma
Olumiant (baricitinib) - Incyte, Eli Lilly
Mitchga (nemolizumab) - Roche, Maruho, Galderma
Dupixent (dupilumab) - Sanofi, Regeneron
asivatrep (PAC-14028) - Amorepacific
Korsuva IV (difelikefalin IV) - Cara Therap, Maruishi Pharma
http://www.ncbi.nlm.nih.gov/pubmed/38186219
 
Laura Maintz; Svenja Müller; Thomas Bieber
 
Jan 8, 2024
 
Prev Next